In 2023, the average length of stay in hospitals for dermatitis, eczema, and papulosquamous disorders in Canada stood slightly above 4.7 days. The forecast from 2024 to 2028 suggests a gradual decrease from 4.7 to 4.4 days, showing a consistent year-on-year reduction. Notably, the average annual decrease (CAGR) over the forecasted period is approximately 1.6%. This decline reflects improvements in treatment efficiency and hospital management practices.

Future trends to watch for:

Advancements in dermatological treatments that could further reduce hospital stays.
Policy changes impacting healthcare delivery and technology adoption in Canadian hospitals.
Healthcare cost management practices that aim to optimize patient health outcomes while reducing length of stay.